mhurhangee/patent-ind-claim-en huggingface dataset:
A process for making an oligosaccharide, or a glycoside of said oligosaccharide, by glycosylating a carbohydrate acceptor which is a monosaccharide or disaccharide and which is not sucrose, or a glycoside of said acceptor, comprising the steps of: a) providing a cell that can internalize said acceptor into said cell and comprises - a recombinant gene encoding a glycosyl transferase which is able to transfer a glycosyl residue of an activated sugar nucleotide to said acceptor, internalized in said cell, and - a biosynthetic pathway to make said activated sugar nucleotide in said cell, b) culturing said cell in the presence of said acceptor and sucrose, and c) separating said oligosaccharide from said cell, from the culture medium or from both, said process being characterized in that said cell also comprises one or more genes encoding a heterologous PTS-dependent sucrose utilization transport system, so that said cell can use sucrose as a carbon source for making said activated sugar nucleotide and as an energy source for making said oligosaccharide, wherein the glycosyl transferase is selected from the group consisting of β-1,3-N-acetylglucosaminyl transferase, β-1,6-N-acetylglucosaminyl transferase, β-1,3-galactosyl transferase, β-1,4-galactosyl transferase, α-1,2-fucosyl transferase, α-1,3-fucosyl transferase and α-1,4-fucosyl transferase. a) providing a cell that can internalize said acceptor into said cell and comprises - a recombinant gene encoding a glycosyl transferase which is able to transfer a glycosyl residue of an activated sugar nucleotide to said acceptor, internalized in said cell, and - a biosynthetic pathway to make said activated sugar nucleotide in said cell, - a recombinant gene encoding a glycosyl transferase which is able to transfer a glycosyl residue of an activated sugar nucleotide to said acceptor, internalized in said cell, and - a biosynthetic pathway to make said activated sugar nucleotide in said cell, b) culturing said cell in the presence of said acceptor and sucrose, and c) separating said oligosaccharide from said cell, from the culture medium or from both, said process being characterized in that said cell also comprises one or more genes encoding a heterologous PTS-dependent sucrose utilization transport system, so that said cell can use sucrose as a carbon source for making said activated sugar nucleotide and as an energy source for making said oligosaccharide, wherein the glycosyl transferase is selected from the group consisting of β-1,3-N-acetylglucosaminyl transferase, β-1,6-N-acetylglucosaminyl transferase, β-1,3-galactosyl transferase, β-1,4-galactosyl transferase, α-1,2-fucosyl transferase, α-1,3-fucosyl transferase and α-1,4-fucosyl transferase.
Board game with a board having at least one playing surface comprising multiple playing fields and with playing pieces and at least one holding device for holding a playing piece releasably attached to the playing field , the playing piece having a vertical orientation, with the board being arranged such that the orientation of the playing surface deviates from a horizontal orientation, wherein a rotating device is provided for rotating the playing piece , characterised in that the rotating device is designed such that, when the board is rotated about an imaginary axis (A) substantially orthogonally to the playing surface , the playing piece rotates to keep the same vertical orientation for any rotation of the board without further manual interaction by the players.
System comprising a rail track the upper end of which is substantially aligned with the surrounding ground, the rail track including at least one rail having a connecting portion to which is connected one end of an electric cable , the system comprising a drainage system including at least one drain channel section having two ends, at least one end being provided with a wall closing said end, the drain channel section further comprising an opening created in the wall and a plug for closing up said opening removable from inside the drain channel section , the drain channel section extending substantially perpendicularly to the rail so that the opening created in the wall faces said connecting portion to form an inspection window for the connection of the end of the electric cable with the rail .
A method for communicating in a wireless network, comprising: receiving , by a wireless device, an indication of a binding between a service data flow and a data radio bearer with an access point; determining , based on the received indication, whether the data radio bearer for binding to the service data flow corresponds to an existing data radio bearer that supports one or more quality-of-service, QoS, parameters of the service data flow, or corresponds to a new data radio bearer to be established with the access point to support the one or more QoS parameters of the service data flow; based on the determination: modifying , by the wireless device and based on the determination, the existing data radio bearer with the access point or establishing, by the wireless device and based on the determination, the new data radio bearer with the access point; and transmitting , by the wireless device in an uplink communication to the access point and based on the binding, a packet using the data radio bearer based at least in part on classifying the packet as related to the service data flow. receiving , by a wireless device, an indication of a binding between a service data flow and a data radio bearer with an access point; determining , based on the received indication, whether the data radio bearer for binding to the service data flow corresponds to an existing data radio bearer that supports one or more quality-of-service, QoS, parameters of the service data flow, or corresponds to a new data radio bearer to be established with the access point to support the one or more QoS parameters of the service data flow; based on the determination: modifying , by the wireless device and based on the determination, the existing data radio bearer with the access point or establishing, by the wireless device and based on the determination, the new data radio bearer with the access point; and transmitting , by the wireless device in an uplink communication to the access point and based on the binding, a packet using the data radio bearer based at least in part on classifying the packet as related to the service data flow.
A method for coating a substrate, the method comprising providing a substrate having a surface; disposing a coating composition adjacent the surface; the composition comprising a hydrophobic fluorinated solvent; a binder comprising a hydrophobic fluorinated polymer, wherein the binder is present in an amount within the range of 0.3 wt.% to 1.5 wt.% of the composition; hydrophobic fumed silica nanoparticles, wherein the silica nanoparticles are present in an amount within the range of 0.01 wt.% to 0.5 wt.% of the composition; and hydrophobic aerogel nanoparticles, wherein the aerogel nanoparticles are present in an amount within the range of 0.1 wt.% to 0.5 wt.% of the composition; and evaporating the fluorinated solvent. providing a substrate having a surface; disposing a coating composition adjacent the surface; the composition comprising a hydrophobic fluorinated solvent; a binder comprising a hydrophobic fluorinated polymer, wherein the binder is present in an amount within the range of 0.3 wt.% to 1.5 wt.% of the composition; hydrophobic fumed silica nanoparticles, wherein the silica nanoparticles are present in an amount within the range of 0.01 wt.% to 0.5 wt.% of the composition; and hydrophobic aerogel nanoparticles, wherein the aerogel nanoparticles are present in an amount within the range of 0.1 wt.% to 0.5 wt.% of the composition; and a hydrophobic fluorinated solvent; a binder comprising a hydrophobic fluorinated polymer, wherein the binder is present in an amount within the range of 0.3 wt.% to 1.5 wt.% of the composition; hydrophobic fumed silica nanoparticles, wherein the silica nanoparticles are present in an amount within the range of 0.01 wt.% to 0.5 wt.% of the composition; and hydrophobic aerogel nanoparticles, wherein the aerogel nanoparticles are present in an amount within the range of 0.1 wt.% to 0.5 wt.% of the composition; and evaporating the fluorinated solvent.
A method for the conservative treatment of at least one symptomatic fruit plant showing symptoms of a disease, comprising the steps of: - identifying the symptomatic plant which has undergone a pruning step; - identifying a period of quiescence of the symptomatic plant ; and - during the period of quiescence, making at least one hole in the trunk of the symptomatic plant until reaching a non-necrotic portion of the xylem ; - introducing during the period of quiescence into the non-necrotic portion of the xylem , by means of said at least one hole , an amount of treatment fluid such as to provoke the discharge of the same treatment fluid from the pruned portions of the symptomatic plant and/or the discharge of sap from the same symptomatic plant . - identifying the symptomatic plant which has undergone a pruning step; - identifying a period of quiescence of the symptomatic plant ; and - during the period of quiescence, making at least one hole in the trunk of the symptomatic plant until reaching a non-necrotic portion of the xylem ; - introducing during the period of quiescence into the non-necrotic portion of the xylem , by means of said at least one hole , an amount of treatment fluid such as to provoke the discharge of the same treatment fluid from the pruned portions of the symptomatic plant and/or the discharge of sap from the same symptomatic plant .
A medicament delivery device comprising: a cartridge assembly comprising a cartridge having a medicament chamber for containing a medicament, a sealing element for sealing a distal end of the medicament chamber, a coupling element attached to the cartridge ; a hub ; a sealing element release member mounted in the hub ; a cannula for delivery of the medicament; and a removable cap engageable with the hub ; the device being switchable by relative movement between the release member and the cartridge assembly from a starting configuration in which the release member is spaced from the sealing element to an activated configuration in which the release member cooperates with the sealing element to connect the medicament chamber to the cannula ; wherein a release member chamber is defined in part by the coupling element and in part by the sealing element , the release member chamber being arranged for receiving the release member such that at least a proximal end of the release member is sealed in the release member chamber when the device is in the starting configuration; and wherein the cap comprises at least one blocking formation , the at least one blocking formation extending through a corresponding aperture in the hub to cooperate with the coupling element of the cartridge assembly a proximal end of the at least one blocking formation cooperating with the coupling element for limiting relative movement between the release member and the cartridge assembly in at least one direction, thereby to keep the device in the starting configuration when the cap is in place. a cartridge assembly comprising a cartridge having a medicament chamber for containing a medicament, a sealing element for sealing a distal end of the medicament chamber, a coupling element attached to the cartridge ; a hub ; a sealing element release member mounted in the hub ; a cannula for delivery of the medicament; and a removable cap engageable with the hub ; the device being switchable by relative movement between the release member and the cartridge assembly from a starting configuration in which the release member is spaced from the sealing element to an activated configuration in which the release member cooperates with the sealing element to connect the medicament chamber to the cannula ; wherein a release member chamber is defined in part by the coupling element and in part by the sealing element , the release member chamber being arranged for receiving the release member such that at least a proximal end of the release member is sealed in the release member chamber when the device is in the starting configuration; and wherein the cap comprises at least one blocking formation , the at least one blocking formation extending through a corresponding aperture in the hub to cooperate with the coupling element of the cartridge assembly a proximal end of the at least one blocking formation cooperating with the coupling element for limiting relative movement between the release member and the cartridge assembly in at least one direction, thereby to keep the device in the starting configuration when the cap is in place.
A dental implantation device suitable for obturation of root canals in teeth that comprises an elongated rod having a lower section , a central section , and an upper section , and is suited to be disposed in a tooth such that the lower section is adapted to be inserted into the bottom or end of a root canal of the tooth , the central section is adapted to be disposed along the length of the root canal , and the upper section is adapted to be disposed outside the root canal of the tooth , wherein the lower section is composed of titanium, and the lower section has a geometry suitable for adaptation and/or incrustation in the area of the bottom or end of the root canal of the tooth , said geometry having a root canal sealing capacity, characterized in that the central section is composed of an alloy of titanium and nickel that is flexible for adaptation and positioning along the root canal , and the central section is coated with a coating of material that is flexible and biocompatible with the interior of the root canal .
A graphene electronic device comprising: a first conductive layer formed on a first region of an intermediate layer and a semiconductor layer formed over the first conductive layer; a second conductive layer formed on a second region spaced from the first region of the intermediate layer; a graphene layer formed on the intermediate layer, the semiconductor layer and the second conductive layer, so that the semiconductor layer is between the first conductive layer and the graphene layer ; and a first gate structure and a second gate structure formed on the graphene layer, so that the graphene layer is between the gate structures and the intermediate layer, wherein the first gate structure is formed in a space that corresponds to the first region of the intermediate layer , wherein the second gate structure is formed in the space between the first region and the second region of the intermediate layer , and wherein there is no gate structure in the second region of the intermediate layer . a first conductive layer formed on a first region of an intermediate layer and a semiconductor layer formed over the first conductive layer; a second conductive layer formed on a second region spaced from the first region of the intermediate layer; a graphene layer formed on the intermediate layer, the semiconductor layer and the second conductive layer, so that the semiconductor layer is between the first conductive layer and the graphene layer ; and a first gate structure and a second gate structure formed on the graphene layer, so that the graphene layer is between the gate structures and the intermediate layer, wherein the first gate structure is formed in a space that corresponds to the first region of the intermediate layer , wherein the second gate structure is formed in the space between the first region and the second region of the intermediate layer , and wherein there is no gate structure in the second region of the intermediate layer .
A synthetic retinal derivative for use in improving visual function of a subject with an endogenous retinoid deficiency, by a method comprising: a. administering a first therapeutic dose of a synthetic retinal derivative, wherein the synthetic retinal derivative is 11-cis-retinyl acetate, 9-cis-retinyl acetate, or 9-cis-retinyl succinate, wherein the first therapeutic dose is administered as a divided dose over a period of from 2 to 7 days; b. providing a resting period of 14 days, 15 days, 16 days, 17 days, 18 days, 19 days, 20 days, 21 days, 22 days, 23 days, 24 days, 25 days, 26 days, or 27 days; and c. administering a second therapeutic dose of the synthetic retinal derivative to said subject following the end of the resting period, wherein the endogenous retinoid deficiency is retinitis pigmentosa (RP) or Leber congenital amaurosis (LCA). a. administering a first therapeutic dose of a synthetic retinal derivative, wherein the synthetic retinal derivative is 11-cis-retinyl acetate, 9-cis-retinyl acetate, or 9-cis-retinyl succinate, wherein the first therapeutic dose is administered as a divided dose over a period of from 2 to 7 days; b. providing a resting period of 14 days, 15 days, 16 days, 17 days, 18 days, 19 days, 20 days, 21 days, 22 days, 23 days, 24 days, 25 days, 26 days, or 27 days; and c. administering a second therapeutic dose of the synthetic retinal derivative to said subject following the end of the resting period,
A non-oriented electrical steel sheet, comprising: Si at 2.0 to 4.0 wt%, Al at 1.5 wt% or less excluding 0 wt%, Mn at 1.5 wt% or less excluding 0 wt%, Cr at 0.02 to 0.5 wt%, V at 0.0080 to 0.015 wt%, C at 0.015 wt% or less excluding 0 wt%, N at 0.015 wt% or less excluding 0 wt%, and the remainder of Fe and other impurities unavoidably added thereto, and satisfying Equation 1 below, wherein the steel sheet optionally comprises at least one of S at 0.005 wt% or less excluding 0 wt%, Ti at 0.005 wt% or less excluding 0 wt%, Nb at 0.005 wt% or less excluding 0 wt%, Cu at 0.025 wt% or less excluding 0 wt%, B at 0.001 wt% or less excluding 0 wt%, Mg at 0.005 wt% or less excluding 0 wt%, and Zr at 0.005 wt% or less excluding 0 wt% as said impurities, wherein grains having a crystal orientation with respect to a cross-section of a steel sheet including the entire thickness layer by an area of 15 mm 2 or more that is within 15 degrees from <uvw> are included at 35 % or more, wherein the orientation fraction is measured 10 times by EBSD with respect to a transverse direction cross-section of a steel sheet using the area of 350 μm × 5000 μm and the 2 μm step interval without overlapping and then calculated as the orientation fraction within the error range of 15 degrees by merging the measured data, 0.004 ≤ C + N ≤ 0.022 , wherein in Equation 1, [C] and [N] represent a content of C and N in wt%, respectively. Si at 2.0 to 4.0 wt%, Al at 1.5 wt% or less excluding 0 wt%, Mn at 1.5 wt% or less excluding 0 wt%, Cr at 0.02 to 0.5 wt%, V at 0.0080 to 0.015 wt%, C at 0.015 wt% or less excluding 0 wt%, N at 0.015 wt% or less excluding 0 wt%, and the remainder of Fe and other impurities unavoidably added thereto, and satisfying Equation 1 below, wherein the steel sheet optionally comprises at least one of S at 0.005 wt% or less excluding 0 wt%, Ti at 0.005 wt% or less excluding 0 wt%, Nb at 0.005 wt% or less excluding 0 wt%, Cu at 0.025 wt% or less excluding 0 wt%, B at 0.001 wt% or less excluding 0 wt%, Mg at 0.005 wt% or less excluding 0 wt%, and Zr at 0.005 wt% or less excluding 0 wt% as said impurities, wherein grains having a crystal orientation with respect to a cross-section of a steel sheet including the entire thickness layer by an area of 15 mm 2 or more that is within 15 degrees from <uvw> are included at 35 % or more, wherein the orientation fraction is measured 10 times by EBSD with respect to a transverse direction cross-section of a steel sheet using the area of 350 μm × 5000 μm and the 2 μm step interval without overlapping and then calculated as the orientation fraction within the error range of 15 degrees by merging the measured data, 0.004 ≤ C + N ≤ 0.022 , wherein in Equation 1, [C] and [N] represent a content of C and N in wt%, respectively.
An additive manufacturing system for manufacturing a 3D object from a build material; the system comprising a build chamber having a build platform for supporting a build material bed , the build chamber divided by the build platform into an upper portion including the build material bed and a lower portion for storing unfused supply build material; the build chamber having a plurality of walls, at least one wall of the plurality of walls bearing, or being associated with, two or more thermal elements , , , , responsive to respective control signals, to influence the temperature of the upper portion of the build chamber ; the two or more thermal elements , , , being disposed in a direction of an axis of movement of the build platform . the system comprising a build chamber having a build platform for supporting a build material bed , the build chamber divided by the build platform into an upper portion including the build material bed and a lower portion for storing unfused supply build material; the build chamber having a plurality of walls, at least one wall of the plurality of walls bearing, or being associated with, two or more thermal elements , , , , responsive to respective control signals, to influence the temperature of the upper portion of the build chamber ; the two or more thermal elements , , , being disposed in a direction of an axis of movement of the build platform .
Use of similar drive batteries in a first vehicle, the first vehicle being equipped with a front drive, and in a second vehicle, the second vehicle being equipped with a rear drive, wherein each drive battery has a battery housing , a plurality of battery modules in the battery housing , a connection of the drive battery and at least one crossmember , preferably a plurality of crossmembers , in the battery housing for boosting the drive battery in the vehicle transverse direction (y), wherein all of the crossmembers are arranged symmetrically with respect to a rotation of the drive battery about a vertical axis (z) through 180 degrees, so that after such a rotation the crossmembers come to rest in the same positions in the vehicle longitudinal direction (x) as before the rotation, wherein the drive battery in the second vehicle is rotated about a vertical axis through 180 degrees, with respect to the arrangement of the drive battery in the first vehicle, so that the crossmembers in the second vehicle lie in the same positions in the vehicle longitudinal direction (x) as in the first vehicle.